BLOG
National Drug Shortages: Can Compounding Pharmacies Assist?
Can Compounding Pharmacies Help With Drug Shortage? | by: Deneen Fumich, RPh | Article Posted: January 30, 2023 | As parents, grandparents and caregivers, we all can relate to the feeling of helplessness when our children become ill. But we all have had the relief of...
Recent Articles
Consolidation is on the Horizon for 503Bs and WDDs
Most of the content you see from Pharma Solutions in regards to the DQSA focuses on Title II: Drug Supply Chain Security Act, which outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. Title II primarily affects manufacturers, 3PLs, drug distributors and pharmacies.
Pending Regulation on Drug Pricing
Bernie Sanders and other top Democrats have made drug pricing a hot topic in US politics, especially with the election coming up next year. As such, there have been a flurry of bills and solutions to the perceived problem – and Drug Importation may become a reality sooner rather than later.
OptumRx Network Policy: VAWD Requirement for Manufacturers and VDIP Accreditation
OptumRx Network Policy: VAWD Requirement for Manufacturers and VDIP Accreditation By now, OptumRx’s VAWD Accreditation requirement has become a...
Anti-Trust Activities in the Dental Supply Market
Anti-Trust Activities in the Dental Supply Market Product access and pricing are always at the center-point of supply chains–and the healthcare...
The Unforeseen Consequence of Colorado’s Insulin Price Cap
The Unforeseen Consequence of Colorado’s Insulin Price Cap Photo courtesy of the Los Angeles Times Drug pricing has been a huge, very public issue...
Nevada Levies $17.4 Million in Fines on Diabetes Drug Manufacturers
The State of Nevada shocked the pharmaceutical supply chain last month by levying an unprecedented $17.4 million in fines due to deficient reporting by drug manufacturers of prescription drugs that are essential for treating diabetes in Nevada.